| 注册
首页|期刊导航|中国临床药理学杂志|新药临床试验申请评价基本考虑

新药临床试验申请评价基本考虑

钱思源 王涛

中国临床药理学杂志Issue(21):2170-2174,5.
中国临床药理学杂志Issue(21):2170-2174,5.DOI:10.13699/j.cnki.1001-6821.2015.21.026

新药临床试验申请评价基本考虑

Main consiration of investigational new drug clinical evaluaion

钱思源 1王涛1

作者信息

  • 1. 国家食品药品监督管理总局 药品审评中心,北京 100038
  • 折叠

摘要

Abstract

Clinical trials are the core of new drug, because efficacy and safety of new drug depends on clinical trials finally.This paper include four contents: evaluation mode of investigational new drug ( IND ) , contents of IND, main points of IND and strategic decision.This paper discusses the current direction of thinking on China Food and Drug Administration Center for Drug Evaluation application for clinical trial.

关键词

新药临床试验/临床评价/创新药物/临床决策

Key words

investigational new drug/clinical evaluation/new drug/clinical dicision

分类

医药卫生

引用本文复制引用

钱思源,王涛..新药临床试验申请评价基本考虑[J].中国临床药理学杂志,2015,(21):2170-2174,5.

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文